Biora Therapeutics Inc (4ZU0) News

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 3 - Initial statement of beneficial ownership of securities

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

Form 8-K - Current report

Form D - Notice of Exempt Offering of Securities

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Form 8-K - Current report

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed pursuant to Rule 424(b)(3) Registration No. 333-268581   PROSPECTUS SUPPLEMENT NO. 2 (to Prospectus dated February 13...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549    FORM 12b-25   NOTIFICATION OF LATE...

Current Report Filing (8-k)

Current Report Filing (8-k)

0001440153 false 0001440153 2023-05-03 2023-05-03   UNITED STATES SECURITIES AND EXCHANGE...

Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)

Filed pursuant to Rule 424(b)(3) Registration No. 333-268581   PROSPECTUS SUPPLEMENT NO. 1 (to Prospectus dated February 13...

Quarterly Report (10-q)

0001440153 --07-31 false 2023 Q2 false 0001440153 2022-08-01 2023-01-31 0001440153 2023-01-31...